| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |